Celldex Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Amgen USD 538M 33.04B 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Celldex Therapeutics USD 66.39M 66.33M 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Roche Holding CHF 107M 0 2024-06


Celldex Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.